Protein Kinases in Cancer Stem Cells, Carcinogenesis, Senescence and Cancer Treatment
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cell Signaling".
Deadline for manuscript submissions: closed (20 November 2023) | Viewed by 1903
Special Issue Editor
Interests: cancerogenesis; cancer cells drug resistance; cell signaling in cancer and normal cells; protein kinases in cancerogenesis; proteomics; confocal microscopy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to bring together cutting-edge research in the field of protein kinases and present advancements in their role in cancer stem cells (CSCs), carcinogenesis, and cancer treatment.
Cancer stem cells have been identified as a critical component in the process of carcinogenesis and are believed to contribute to tumor initiation, progression, and therapy resistance. Despite their significance, the precise mechanisms underlying the involvement of protein kinase networks in the regulation of cancer stem cells still await detailed elucidation.
As part of this Special Issue, we are particularly encouraging your contributions that shed light on the role of protein kinase networks in cancer cell senescence, as this emerging area holds great promise as a novel therapeutic strategy. Understanding the mechanisms of cancer cell senescence and its connection to protein kinase signaling pathways is vital for developing novel therapeutic strategies.
By elucidating the dysregulation of protein kinases in carcinogenesis and exploring their potential as therapeutic targets, we can pave the way for innovative approaches to cancer therapy and personalized medicine.
We invite you to submit a manuscript that addresses one or more of the following topics:
- Protein kinase signaling pathways in cancer stem cells;
- Dysregulation of protein kinases in carcinogenesis;
- Novel therapeutic strategies targeting protein kinases for cancer therapy and personalized medicine;
- Protein kinases and therapy resistance in cancer;
- Targeting cancer cell senescence via protein kinase networks.
Your valuable research insights and findings in any of these areas would greatly enrich the scientific knowledge and advancements in the field. We encourage you to share your expertise and contribute to this Special Issue, as your contributions can play a significant role in shaping the future of cancer research and treatment.
Dr. Mindaugas Valius
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- protein kinase
- cancer stem cell
- senescence
